Maternal Use of the SSRI Antidepressant Fluoxetine Linked To Fatty Liver

A new animal study has found that adult offspring of mothers who used fluoxetine, a common antidepressant, during pregnancy were more likely to develop a fatty liver.

The results will be reported Saturday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

Antidepressant Use During Pregnancy Linked to Childhood Obesity and Diabetes
A new study has found that women who take antidepressants during pregnancy could be unknowingly disposing their infants to type 2 diabetes and obesity

"When mothers take antidepressants during pregnancy, they may be predisposing their children to metabolic disturbances, including obesity and fatty liver in adulthood," said, the study's senior investigator, Alison Holloway, PhD, associate professor, McMaster University, Hamilton, Ontario.

Fluoxetine (marketed as Prozac®) is in a class of antidepressants called selective serotonin reuptake inhibitors, or SSRIs. Although adults taking antidepressants have an increased risk of obesity and Type 2 diabetes, Holloway said it is unclear whether a woman's use of an SSRI during pregnancy increases the risk of metabolic problems in her children.

To learn the answer to this question, researchers at several Canadian institutions collaborated on this study, which received funding from the Canadian Institutes of Health Research. The investigators studied the consequences of fetal exposure to fluoxetine in rats, which Holloway called a good model for liver and metabolic disorders in humans.

More Kids Use Antipsychotic, Antidepressant Drugs In Australia, Study Shows
More Aussie kids have begun using powerful antipsychotic, antidepressant medications, a study shows.

Presenting author Nicole De Long, a PhD student at McMaster, gave 15 female rats the antidepressant (at a daily dosage of 10 milligrams per kilogram of body weight) mixed in plain gelatin for two weeks before mating, during pregnancy and during lactation until weaning their young. As controls, another 15 female rats received the gelatin without the drug for the same period.

When the offspring were 26 weeks old—an age considered young adulthood—the researchers assessed the rats' livers for presence of fatty liver disease, also called nonalcoholic steatohepatitis, as well as for levels of liver lipids (fats) and markers of inflammation.

New Insights of Developing Rapid-Acting Antidepressant for Treatment-Resistant Depression
Researchers at UT Southwestern Medical Center have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression.

Compared with offspring of control rats, the offspring of fluoxetine-treated rats more often had signs of mild to moderate fatty liver disease, the authors reported. These rats also had higher levels of triglycerides and cholesterol in the liver.

Both male and female offspring of fluoxetine-exposed mothers also showed increased inflammation in the liver. This inflammation and increased accumulation of fat in the liver is associated with metabolic abnormalities, including obesity and Type 2 diabetes.

Link Between Weight Gain and Antidepressant Use Examined
Question of use of antidepressant leading to weight gain has been common among the drug users and scientists alike.

"We think it is possible that prenatal exposure to SSRI antidepressants may contribute to obesity and Type 2 diabetes in the children," Holloway commented.

This study provides the first evidence that children exposed to SSRIs in the womb may have increased risk of fatty liver disease," she said. "Exposed children may need monitoring and lifestyle interventions targeting obesity and diabetes prevention."

About 10 to 15 percent of pregnant women take antidepressants, past research shows.

Source-Eurekalert